Mastitis medical therapy

Jump to navigation Jump to search

Mastitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mastitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Mastitis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mastitis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mastitis medical therapy

CDC on Mastitis medical therapy

Mastitis medical therapy in the news

Blogs on Mastitis medical therapy

Directions to Hospitals Treating Mastitis

Risk calculators and risk factors for Mastitis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]

Overview

Supportive care is the mainstay of therapy for puerperal mastitis. Supportive therapy includes massage, heat application, cold compresses and frequent breastfeeding. The treatment for non-puerperal mastitis is based on the underlying condition. Pharmacological therapies for non-puerperal mastitis include prolactin inhibiting agents, antimicrobial therapy, and nonsteroidal anti-inflammatory drugs (NSAIDs). Granulomatous mastitis has been treated with some success by a combination of steroids and prolactin inhibiting medications.

Medical Therapy

Puerperal Mastitis

Massage and the application of heat can help prior to feeding as this will aid the opening of the ducts and passageways. A cold compress may be used to ease the pain when not wanting to lose the milk, though it is most appropriate to reduce the levels of milk contained. For this reason it is also advised that the baby should frequently feed from the inflamed breast. However, the content of the milk may be slightly altered, sometimes being more salty, and the taste may make the baby reject the breast at the first instance.

The presence of cracks or sores on the nipples increases the likelihood of infection. Tight clothing or ill-fitting bras may also cause problems as they compress the breasts. The most common infecting organism is Staph. aureus, and babies carrying the organism in their noses are more likely to give it to their mothers;[1] the clinical significance of this finding is still unknown, but theoretically, removing carriage from the nursing infant's nose may help prevent recurrence.

In severe cases it may be required to stop lactation and use lactation inhibiting medication.

Non-puerperal Mastitis

  • Treatment according to presumed cause, diagnosis and treatment of underlying condition is very important.
  • Prolactin inhibiting medication has been shown to be most effective and reduce risk of recurrence.[2][3]
  • More exotic treatments for non-puerperal mastitis that have been mentioned to show at least some efficacy include local and systemic progestins or progesterone [2][3], antidiuretics, Vitex Agnus Castus extract and Danazol.
  • Many variants of surgical procedures such as duct resection have been tried to reduce the risk of recurrent subareolar abscesses. So far the success rates are limited and conservative treatment seems preferable where possible.
  • Approximately 30% of cases develop chronic or recurring mastitis requiring long term or indefinite treatment with prolactin inhibiting medication.[2][3]

Granulomatous mastitis

  • Steroid is the treatment of choice with or without prolactin inhibiting medications although a gold standard treatment modality has not been well established.[4][5]
  • Metothrexate and azathioprine can be added to maintain remission.[6]

Antimicrobial regimen

References

  1. Amir LH, Garland SM, Lumley J. (2006). "A case-control study of mastitis: nasal carriage of Staphylococcus aureus". BMC Family Practice. 7: 57. doi:10.1186/1471-2296-7-57.
  2. 2.0 2.1 2.2 Pahnke VG, Goepel E (1994). "[Non-puerperal mastitis: a disease without end? (Results of a long-term study)]". Geburtshilfe Frauenheilkd. 54 (3): 155–60. doi:10.1055/s-2007-1023572. PMID 8188014.
  3. 3.0 3.1 3.2 Goepel E, Pahnke VG (1991). "[Successful therapy of nonpuerperal mastitis--already routine or still a rarity?]". Geburtshilfe Frauenheilkd. 51 (2): 109–16. doi:10.1055/s-2007-1023685. PMID 2040409.
  4. Altintoprak F, Kivilcim T, Yalkin O, Uzunoglu Y, Kahyaoglu Z, Dilek ON (2015). "Topical Steroids Are Effective in the Treatment of Idiopathic Granulomatous Mastitis". World J Surg. 39 (11): 2718–23. doi:10.1007/s00268-015-3147-9. PMID 26148520.
  5. Zhang LN, Shi TY, Yang YJ, Zhang FC (2014). "An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine". Lupus. 23 (4): 417–20. doi:10.1177/0961203313520059. PMID 24446305.
  6. Peña-Santos G, Ruiz-Moreno JL (2011). "[Idiopathic granulomatous mastitis treated with steroids and methotrexate]". Ginecol Obstet Mex. 79 (6): 373–6. PMID 21966829.
  7. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL; et al. (2014). "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America". Clin Infect Dis. 59 (2): 147–59. doi:10.1093/cid/ciu296. PMID 24947530.

Template:WH Template:WS